Complicated and Controversial Considerations Regarding Estrogen Replacement Therapy

  • Nelson B. Watts
Part of the Clinical Perspectives in Obstetrics and Gynecology book series (CPOG)


The woman with cardiac disease (e.g., acute myocardial infarction, valve surgery, etc). If the patient is already taking estrogen at the time of myocardial infarction or cardiac surgery, therapy may be continued as before. There is no logical reason why estrogen therapy, once initiated, should be stopped for an acute cardiac event. If estrogen has not been prescribed previously but is felt to be indicated, therapy may be initiated right away.


Systemic Lupus Erythematosus Connective Tissue Disease Total Body Irradiation Estrogen Therapy Ovarian Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. Br Med J. 1988; 297: 519–522.CrossRefGoogle Scholar
  2. 2.
    Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med. 1991; 151: 75–78.PubMedCrossRefGoogle Scholar
  3. 3.
    Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med. 1985; 313: 1038–1043.PubMedCrossRefGoogle Scholar
  4. 4.
    Marcus R, Madvig P, Crim M, Pont A, Kosek J. Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism. Ann Intern Med. 1984; 100: 633–640.PubMedGoogle Scholar
  5. 5.
    Selby PL, Peacock ML. Ethinly estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. N Engl J Med. 1986; 314: 1481–1485.PubMedCrossRefGoogle Scholar
  6. 6.
    Young RL, Goepfert AR, Goldzieher HW. Estrogen replacement therapy is not conducive of venous thromboembolism. Maturitas. 1991; 13: 189–192.PubMedCrossRefGoogle Scholar
  7. 7.
    Devor M, Barrett-Connor E, Renvall M, Feigal D Jr., Ramsdell J. Estrogen replacement therapy and the risk of venous thrombosis. Am J Med. 1992; 92: 275–282.PubMedCrossRefGoogle Scholar
  8. 8.
    Lobo RA. Estrogen and the risk of coagulopathy. Am J Med. 1992; 92: 283–285.PubMedCrossRefGoogle Scholar
  9. 9.
    Cust MP, Whitehead MI, Powles R, Hunter M, Milliken S. Consequences and treatment of ovarian failure after total body irradiation for leukaemia. Br Med J. 1989; 299: 1494–1497.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1994

Authors and Affiliations

  • Nelson B. Watts

There are no affiliations available

Personalised recommendations